The ability to upregulate SIRT3 to maintain mitochondrial integrity and antioxidative defense mechanisms offers potential therapeutic interventions for tackling age-related declines in oocyte quality and mitigating the impacts of metabolic disorders like obesity and PCOS on fertility. Here, SIRT3 is linked to polycystic ovary syndrome.